"Le Centre Hospitalier Universitaire de Toulouse, constitué de plusieurs établissements répartis au nord et au sud de la ville, est un lieu d’accueil, d’hébergement et de soins au service de tous ceux qui, à un certain moment de leur vie, sont confrontés à la maladie et à la souffrance."

During the past decade, CHU toulouse - Hôpital Purpan; Departement de Neurologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU toulouse - Hôpital Purpan; Departement de Neurologie" #1 collaborator was "Avid Radiopharmaceuticals" with 1 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CHU toulouse - Hôpital Purpan; Departement de Neurologie" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Relapsing Multiple Sclerosis" (2 trials), "Huntingtons Disease" (1 trials), "Intracerebral Hemorrhage" (1 trials) and "Myasthenia Gravis" (1 trials). Many other conditions were trialed in "CHU toulouse - Hôpital Purpan; Departement de Neurologie" in a lesser frequency.

Most popular intervention types in "CHU toulouse - Hôpital Purpan; Departement de Neurologie" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (3 trials), "IGIV-C" (2 trials), "Fenebrutinib" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU toulouse - Hôpital Purpan; Departement de Neurologie" are 9 trials for "All" genders.

Currently, there are NaN active trials in "CHU toulouse - Hôpital Purpan; Departement de Neurologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in CHU toulouse - Hôpital Purpan; Departement de Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU toulouse - Hôpital Purpan; Departement de Neurologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".